Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer (Q71093076)
Jump to navigation
Jump to search
scientific article published on 01 February 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer |
scientific article published on 01 February 1996 |
Statements
Phase I study of etoposide with SDZ PSC 833 as a modulator of multidrug resistance in patients with cancer (English)
D J Boote
I F Dennis
P R Twentyman
R J Osborne
C Laburte
S Hensel
J F Smyth
M H Brampton
1 February 1996